文献速递主动脉疾病

EVAR预后与腹主动脉瘤直径、体积及术后早期变化的关系

Comparison of Outcomes Following EVAR Based on Aneurysm Diameter and Volume and Their Postoperative Variations.
PubMed 文献 · Ann Vasc Surg · 2021-02-04

结果显示术前AAA直径>59 mm、体积>159 cm3及术后30天内任何直径或体积增大均与再干预及死亡显著相关。

要点

  • 术前AAA直径>59 mm、体积>159 cm3与随访期再干预及死亡风险升高相关。
  • 术后30天CTA显示瘤体直径或体积任何增大,均与再干预及死亡显著相关。
  • 内漏相关再干预与所有分析的形态学参数均显著相关。

核心结论

  • 基线AAA尺寸和体积较大及瘤囊早期重塑不良的患者,长期EVAR结局更差。

研究设计与样本

  • 回顾所有患者术前及术后30天CTA图像。
  • 术前最大AAA直径>59 mm、体积>159 cm3及30天CTA任何增大被视为可能影响结局的因素。

主要发现

  • 平均术前与30天AAA直径分别为50.4 mm±11.8与49.1 mm±12.1,体积分别为112.9 cm3±79.5与112.1 cm3±80.5。
  • 全部病例获得初次技术成功;随访34.9个月,累积再干预率12.0%,死亡率7.2%,无AAA相关死亡。
  • 内漏相关再干预率为7.5%。

关键数值与推荐

  • 术前AAA直径>59 mm与再干预显著相关(P=0.012),与再干预和死亡显著相关(P=0.002)。
  • 术前AAA体积>159 cm3与再干预显著相关(P=0.002),与再干预和死亡显著相关(P=0.001)。
  • 术后AAA直径或体积任何增大与再干预显著相关(P=0.001,P=0.001),与再干预和死亡显著相关(P=0.006,P=0.001)。
  • 内漏相关再干预与所有分析的形态学参数均显著相关(P=0.019、P=0.005、P=0.005、P=0.002)。

临床怎么用

  • EVAR术前可结合AAA直径与体积评估远期再干预和死亡风险。
  • 术后30天CTA若见瘤体直径或体积增大,应加强随访并警惕再干预需求。

局限性

  • 为双中心回顾性分析,虽数据前瞻性收集,仍可能存在选择偏倚。
  • 随访时间与样本量有限,形态学阈值需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: to evaluate the impact of bi- and 3-dimensional preoperative aortic morphological features and their immediate postoperative variations on the outcome of abdominal aortic aneurysms (AAA) treated by endovascular exclusion with standard devices (EVAR). MATERIALS AND METHODS: Double centre retrospective analysis of prospectively collected registry data of EVAR patients. For all patients, preoperative and 30-day computed tomographic angiography images (CTA) were reviewed. Preoperative maximum AAA diameter >59 mm and volume >159 cm3, and any 30-day postoperative increasing at CTA, were considered as potentially influencing the outcome. The outcome measures were: primary technical success; 30-day, 1-year, and mean follow-up reintervention, all-cause and AAA-related mortality rates, and also endoleak-related reinterventions. RESULTS: Three hundred and thrity-three patients were enrolled. Mean preoperative and 30-day AAA diameter and volume were 50.4 mm ± 11.8 vs. 49.1 mm ± 12.1, and 112.9 cm3 ± 79.5 vs. 112.1 cm3 ± 80.5, respectively. Primary technical success was achieved in all cases. At 34.9 months follow-up, cumulative reintervention rate was 12.0%, mortality rates 7.2%, without AAA-related deaths. Endoleak-related reintervention rate was 7.5%. At uni- and multi-variate analysis, preoperative AAA diameter >59 mm, and AAA volume >159 cm3 were significantly associated to reintervention (P = 0.012; P = 0.002), and reintervention and death (P = 0.002; P = 0.001) during follow-up. Additionally, any increase in postoperative AAA diameter or volume was significantly associated with reintervention (P = 0.001, P = 0.001) and reintervention and death (P = 0.006, P = 0.001). Endoleak-related reintervention were also significantly associated with all of the analysed morphological parameters (P = 0.019, P = 0.005, P = 0.005, and P = 0.002, respectively). CONCLUSIONS: Patients with larger baseline AAA size and volume as well as unfavourable early remodelling of the sac are associated to worse long-term EVAR outcome.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Montelione N, Sirignano P, d'Adamo A, et al. Comparison of Outcomes Following EVAR Based on Aneurysm Diameter and Volume and Their Postoperative Variations. Ann Vasc Surg. 2021. PMID: 33549787. doi:10.1016/j.avsg.2020.12.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。